Skip to main content

Levocetirizine Pregnancy and Breastfeeding Warnings

Brand names: Levrix, Xyzal, Xyzal Allergy 24HR

Levocetirizine Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: B

Animal studies have failed to reveal evidence of fetal harm and teratogenicity. There are no controlled data in human pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Levocetirizine Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-Cetirizine, the racemic form of this drug, has been reported to be excreted into human breast milk and thus it is expected that levocetirizine may be excreted in breast milk.
-Larger doses or prolonged use of this drug may cause drowsiness and other effects in the nursing infant or possibly decrease the milk supply, particularly if used in combination with a sympathomimetic (e.g., pseudoephedrine) or before lactation is well established.

See references

See also

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
  2. (2007) "Product Information. Xyzal (levocetirizine)." UCB Pharma Inc

References for breastfeeding information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
  2. (2007) "Product Information. Xyzal (levocetirizine)." UCB Pharma Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer